Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Asian Elephant T Cell Responses to Elephant Endotheliotropic Herpesvirus.

Fuery A, Leen AM, Peng R, Wong MC, Liu H, Ling PD.

J Virol. 2018 Feb 26;92(6). pii: e01951-17. doi: 10.1128/JVI.01951-17. Print 2018 Mar 15.

2.

EPIDEMIOLOGIC EVALUATION OF ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 3B INFECTION IN AN AFRICAN ELEPHANT (LOXODONTA AFRICANA).

Bronson E, McClure M, Sohl J, Wiedner E, Cox S, Latimer EM, Pearson VR, Hayward GS, Fuery A, Ling PD.

J Zoo Wildl Med. 2017 Jun;48(2):335-343. doi: 10.1638/2016-0063R.1.

PMID:
28749266
3.

Erratum to 'Generation and validation of new quantitative real time PCR assays to detect Elephant Endotheliotropic herpesviruses 1A, 1B, and 4' [J. Virol. Methods 237 (2016) 138-142].

Pursell T, Tan J, Peng R, Ling PD.

J Virol Methods. 2017 Feb;240:85-86. doi: 10.1016/j.jviromet.2016.12.005. No abstract available.

PMID:
28012506
4.

Generation and validation of new quantitative real time PCR assays to detect elephant endotheliotropic herpesviruses 1A, 1B, and 4.

Pursell T, Tan J, Peng R, Ling PD.

J Virol Methods. 2016 Nov;237:138-142. doi: 10.1016/j.jviromet.2016.08.010. Epub 2016 Aug 16. Erratum in: J Virol Methods. 2017 Feb;240:85-86.

PMID:
27542531
5.

Comparison of the Gene Coding Contents and Other Unusual Features of the GC-Rich and AT-Rich Branch Probosciviruses.

Ling PD, Long SY, Zong JC, Heaggans SY, Qin X, Hayward GS.

mSphere. 2016 Jun 15;1(3). pii: e00091-16. doi: 10.1128/mSphere.00091-16. eCollection 2016 May-Jun.

6.

Complete Genome Sequence of Elephant Endotheliotropic Herpesvirus 4, the First Example of a GC-Rich Branch Proboscivirus.

Ling PD, Long SY, Fuery A, Peng RS, Heaggans SY, Qin X, Worley KC, Dugan S, Hayward GS.

mSphere. 2016 Jun 15;1(3). pii: e00081-15. doi: 10.1128/mSphere.00081-15. eCollection 2016 May-Jun.

7.

CLINICAL INFECTION OF TWO CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS) WITH ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 1B.

Fuery A, Tan J, Peng R, Flanagan JP, Tocidlowski ME, Howard LL, Ling PD.

J Zoo Wildl Med. 2016 Mar;47(1):319-24. doi: 10.1638/2015-0074.1.

PMID:
27010294
8.

CLINICAL INFECTION OF CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS) WITH ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 4.

Fuery A, Browning GR, Tan J, Long S, Hayward GS, Cox SK, Flanagan JP, Tocidlowski ME, Howard LL, Ling PD.

J Zoo Wildl Med. 2016 Mar;47(1):311-8. doi: 10.1638/2015-0072.1.

PMID:
27010293
9.

EBNA2 and Its Coactivator EBNA-LP.

Kempkes B, Ling PD.

Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2. Review.

PMID:
26428371
10.

Erratum to: A novel antigen capture ELISA for the specific detection of IgG antibodies to elephant endotheliotropic herpes virus.

van den Doel PB, Prieto VR, van Rossum-Fikkert SE, Schaftenaar W, Latimer E, Howard L, Chapman S, Masters N, Osterhaus AD, Ling PD, Dastjerdi A, Martina B.

BMC Public Health. 2015 Sep 3;15:851. doi: 10.1186/s12889-015-2178-3. No abstract available.

11.

A novel antigen capture ELISA for the specific detection of IgG antibodies to elephant endotheliotropic herpes virus.

van den Doel PB, Prieto VR, van Rossum-Fikkert SE, Schaftenaar W, Latimer E, Howard L, Chapman S, Masters N, Osterhaus AD, Ling PD, Dastjerdi A, Martina B.

BMC Vet Res. 2015 Aug 14;11:203. doi: 10.1186/s12917-015-0522-6. Erratum in: BMC Public Health. 2015;15:851.

12.

The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.

Friberg A, Thumann S, Hennig J, Zou P, Nössner E, Ling PD, Sattler M, Kempkes B.

PLoS Pathog. 2015 May 29;11(5):e1004910. doi: 10.1371/journal.ppat.1004910. eCollection 2015 May.

13.

Generation and characterization of antibodies against Asian elephant (Elephas maximus) IgG, IgM, and IgA.

Humphreys AF, Tan J, Peng R, Benton SM, Qin X, Worley KC, Mikulski RL, Chow DC, Palzkill TG, Ling PD.

PLoS One. 2015 Feb 6;10(2):e0116318. doi: 10.1371/journal.pone.0116318. eCollection 2015.

14.

Detection of elephant endotheliotropic herpesvirus infection among healthy Asian elephants (Elephas maximus) in South India.

Stanton JJ, Nofs SA, Zachariah A, Kalaivannan N, Ling PD.

J Wildl Dis. 2014 Apr;50(2):279-87. doi: 10.7589/2012-09-236. Epub 2014 Jan 31.

PMID:
24484479
15.

Murine gammaherpesvirus 68 encodes a second PML-modifying protein.

Sewatanon J, Ling PD.

J Virol. 2014 Mar;88(6):3591-7. doi: 10.1128/JVI.03081-13. Epub 2013 Dec 26.

16.

Acute phase protein expression during elephant endotheliotropic herpesvirus-1 viremia in Asian elephants (Elephas maximus).

Stanton JJ, Cray C, Rodriguez M, Arheart KL, Ling PD, Herron A.

J Zoo Wildl Med. 2013 Sep;44(3):605-12.

PMID:
24063088
17.

Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells.

Sewatanon J, Liu H, Ling PD.

J Virol. 2013 Nov;87(22):12151-7. doi: 10.1128/JVI.01696-13. Epub 2013 Aug 28.

18.

Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus).

Nofs SA, Atmar RL, Keitel WA, Hanlon C, Stanton JJ, Tan J, Flanagan JP, Howard L, Ling PD.

Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):308-11. doi: 10.1016/j.vetimm.2013.03.008. Epub 2013 Mar 26.

PMID:
23582266
19.

Complete Genome Sequence of Elephant Endotheliotropic Herpesvirus 1A.

Ling PD, Reid JG, Qin X, Muzny DM, Gibbs R, Petrosino J, Peng R, Zong JC, Heaggans SY, Hayward GS.

Genome Announc. 2013 Apr 11;1(2):e0010613. doi: 10.1128/genomeA.00106-13.

20.
21.

Elephant endotheliotropic herpesvirus 5, a newly recognized elephant herpesvirus associated with clinical and subclinical infections in captive Asian elephants (Elephas maximus).

Atkins L, Zong JC, Tan J, Mejia A, Heaggans SY, Nofs SA, Stanton JJ, Flanagan JP, Howard L, Latimer E, Stevens MR, Hoffman DS, Hayward GS, Ling PD.

J Zoo Wildl Med. 2013 Mar;44(1):136-43.

22.

Kinetics of viral loads and genotypic analysis of elephant endotheliotropic herpesvirus-1 infection in captive Asian elephants (Elephas maximus).

Stanton JJ, Zong JC, Eng C, Howard L, Flanagan J, Stevens M, Schmitt D, Wiedner E, Graham D, Junge RE, Weber MA, Fischer M, Mejia A, Tan J, Latimer E, Herron A, Hayward GS, Ling PD.

J Zoo Wildl Med. 2013 Mar;44(1):42-54.

23.

Development and validation of quantitative real-time polymerase chain reaction assays to detect elephant endotheliotropic herpesviruses-2, 3, 4, 5, and 6.

Stanton JJ, Nofs SA, Peng R, Hayward GS, Ling PD.

J Virol Methods. 2012 Dec;186(1-2):73-7. doi: 10.1016/j.jviromet.2012.07.024. Epub 2012 Jul 27.

24.

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.

Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD.

PLoS One. 2011;6(11):e27271. doi: 10.1371/journal.pone.0027271. Epub 2011 Nov 10.

25.

Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression.

Kim YE, Lee JH, Kim ET, Shin HJ, Gu SY, Seol HS, Ling PD, Lee CH, Ahn JH.

J Virol. 2011 Nov;85(22):11928-37. doi: 10.1128/JVI.00758-11. Epub 2011 Aug 31.

26.
27.

Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function.

Ling PD, Tan J, Peng R.

J Virol. 2009 Jul;83(14):7109-16. doi: 10.1128/JVI.00654-09. Epub 2009 Apr 29.

28.

Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.

Echendu CW, Ling PD.

J Interferon Cytokine Res. 2008 Nov;28(11):667-78. doi: 10.1089/jir.2008.0023.

29.

Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus.

Ling PD, Tan J, Sewatanon J, Peng R.

J Virol. 2008 Aug;82(16):8000-12. doi: 10.1128/JVI.02752-07. Epub 2008 May 28.

30.

Isolation and immortalization of lymphocytes.

Ling PD, Huls HM.

Curr Protoc Mol Biol. 2005 May;Chapter 28:Unit 28.2. doi: 10.1002/0471142727.mb2802s70.

PMID:
18265367
31.

Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Ling PD, Peng RS, Nakajima A, Yu JH, Tan J, Moses SM, Yang WH, Zhao B, Kieff E, Bloch KD, Bloch DB.

EMBO J. 2005 Oct 19;24(20):3565-75. Epub 2005 Sep 22.

33.

EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli.

Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD.

J Virol. 2004 Nov;78(22):12694-7.

34.

Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.

Walling DM, Ling PD, Gordadze AV, Montes-Walters M, Flaitz CM, Nichols CM.

J Infect Dis. 2004 Jul 15;190(2):396-9. Epub 2004 Jun 11.

PMID:
15216478
35.

EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Gordadze AV, Onunwor CW, Peng R, Poston D, Kremmer E, Ling PD.

J Virol. 2004 Apr;78(8):3919-29.

36.

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.

Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, Visnegarwala F, Lewis DE, Butel JS.

Clin Infect Dis. 2003 Nov 1;37(9):1244-9. Epub 2003 Sep 23.

PMID:
14557970
37.

Multiple Epstein-Barr virus infections in healthy individuals.

Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD.

J Virol. 2003 Jun;77(11):6546-50.

38.

The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study.

Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng R, Liu Z, Mehta SK, Pierson DL, Rooney CM, Vilchez RA, Smith EO, Butel JS.

J Infect Dis. 2003 May 15;187(10):1571-80. Epub 2003 Apr 30.

PMID:
12721937
39.

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.

O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.

J Med Virol. 2002 Jul;67(3):320-6.

PMID:
12116021
40.
41.

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM.

J Immunol. 2002 Jan 15;168(2):909-18.

42.

Retraction.

Moore PS, Chang Y, Thlick AE, Ling PD, Yu J.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12313. No abstract available.

43.

Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.

Gordadze AV, Peng R, Tan J, Liu G, Sutton R, Kempkes B, Bornkamm GW, Ling PD.

J Virol. 2001 Jul;75(13):5899-912.

45.

Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

Fuentes-Pananá EM, Peng R, Brewer G, Tan J, Ling PD.

J Virol. 2000 Sep;74(17):8166-75.

46.

Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Peng R, Gordadze AV, Fuentes Pananá EM, Wang F, Zong J, Hayward GS, Tan J, Ling PD.

J Virol. 2000 Jan;74(1):379-89.

47.

Supplemental Content

Support Center